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ABSTRACT 
 
The Potential Roles of Cyclooxygenase-2 and 
Matrix Metalloproteinase-9 in Cytomegalovirus-
Infected Atherosclerotic Aorta and Coronary 
Artery 
 
 
Chronic infection and inflammation have recently been 
implicated as important etiologic agents of atherosclerosis. Several 
agents have been suggested as possible candidates including 
cytomegalovirus (CMV), herpes simplex virus type 1 (HSV-1), 
Epstein-Barr virus (EBV), Chlamydia pneumoniae, and 
Helicobacter pylori. This study hypothesized that a vascular 
infection with CMV may induce a chronic inflammatory reaction 
and activated inflammatory cells may express inflammatory 
mediators such as cyclooxygenase-2 (COX-2) and matrix 
metalloproteinases-9 (MMP-9). At first, the relationship between 
cytomegalovirus infection and atherosclerosis was evaluated by in 
situ hybridization and polymerase chain reaction (PCR) study, and 
  xi
then, to confirm the hypothesis, the immunohistochemical study for 
the inflammatory mediators of atherosclerotic plaques was 
performed. This study examined 23 subjects with atherosclerosis 
and 10 matched control subjects without atherosclerosis. CMV was 
detected by in situ hybridization in 60.9% (14/23) of aorta and 
42.9% (9/21) of coronary arteries in subjects with atherosclerosis. It 
was also detected by PCR in 65.2% (15/23) of aorta and 
52.4%(11/21) of coronary arteries. CMV was detected on areas 
showing early or advanced atheromatous changes. 
Subsequently, the immunohistochemical stains for CMV late 
antigen, COX-2, MMP-9, macrophage, and T-lymphocyte were 
performed in the cases from which CMV was detected by in situ 
hybridization and PCR. The immunoreactivity for COX-2 and 
MMP-9 increased in the atherosclerotic plaques itself, 
predominantly around CMV detected area. These findings seem to 
support the hypothesis and CMV may play a pathogenetic role in 
atherogenesis or progression of atherosclerosis. 
Cells morphologically identical to smooth muscle cells, 
endothelial cells, lymphocytes, fibroblasts, and Schwann cells were 
positively reacted with the CMV probe. However, none of the cells 
to which the probe hybridized contained inclusion bodies, thus 
  xii
strongly suggesting that the arterial wall may be a site of CMV 
latency. 
Therefore, these data seem to support the hypothesis that CMV 
may potentially play a direct or indirect role in the pathogenesis of 
human atherosclerosis. 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: cytomegalovirus (CMV), atherosclerosis, cyclooxygenase-2 
(COX-2), matrix metalloproteinase-9 (MMP-9), in situ hybridization, 
polymerase chain reaction, immunohistochemical staining  
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CHAPTER I 
 
 
 
Detection of Cytomegalovirus in Atherosclerotic 
Aorta and Coronary Artery 
by In Situ Hybridization and PCR 
  2
I. INTRODUCTION 
 
More than half of the population of developed countries is dying as 
a result of cardiovascular disease or stroke primarily, although not 
exclusively, related to atherosclerosis. Atherosclerosis is characterized 
grossly by diffuse narrowing of the aorta or coronary arteries and 
microscopically by a concentric fibrointimal thickening with a 
proliferation of smooth muscle cells and infiltration of lipid-laden 
macrophages and T-lymphocytes (Figure I-1) (Hruban et al., 1990). 
Conventional risk factors including hyperlipidemia, hypertension, 
diabetes, cigarette smoking, sex, and family history of premature 
vascular disease account only for approximately half of the patients 
with clinically apparent atherosclerosis (Nieminen et al., 1993). As 
many as 50% of patients with atherosclerosis lack currently identified 
risk factors, an observation indicating that additional factors 
predisposing to atherosclerosis are as yet undetected. The 
pathogenesis of atherosclerosis is a subject of much debate, covered 
by theories such as the monoclonal hypothesis (Benditt et al., 1973) 
and the response to injury hypothesis (Ross et al., 1993). The former 
is based on the observation that 75% of atherosclerotic plaques from 
human tissues that were removed at surgery or at autopsy showed a 
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monoclonal phenotype of the glucose-6-phosphate dehydrogenase (G-
6-PD) enzyme as identified by electrophoretic mobility. Monoclonal 
hypothesis proponents argue that the smooth muscle cell proliferation 
seen in the atherosclerotic lesion is similar to that in a benign tumor 
(Linder et al., 1965). On the other hand, the response to injury 
hypothesis reviewed by Ross et al. (1993) has gained widespread 
acceptance as a conceptual framework for understanding the 
pathogenesis of atheroslcerosis. But the clinically important 
‘injurious’ agents that are responsible for initiating atherosclerosis 
remain elusive. Recently, a potential link between infectious agents 
and atherosclerosis has been suggested. Data obtained from several 
seroepidemiological studies have given rise to the hypothesis that an 
infection can initiate or maintain the atherosclerotic process (Danesh 
et al., 1997).  
Viruses have long been suspected of playing a role in 
cardiovascular diseases, particularly the cardiomyopathies and certain 
chronic valvular diseases of unknown etiology. Experimental studies 
by Fabricant et al. (1978; 1981; 1983) clearly established that 
infection of normocholesterolemic chickens with Marek’s disease 
virus (MDV), a herpesvirus, led to an arterial disease that closely 
resembled chronic human atherosclerosis. Marek’s herpesvirus 
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infection was also shown to alter aortic cholesterol metabolism and 
enhance cholesterol and cholesteryl ester accumulation in infected 
chickens and in cultured arterial smooth muscle cells (Fabricant et al., 
1981; Hajjar et al., 1986). These findings have stimulated interest in 
the possible role of herpesviruses as initiating or accelerating factors 
in human atherogenesis. 
In fact, clinical, epidemiological, in vitro and in vivo studies has 
also implicated a relationship between herpesviruses and 
atherosclerosis in human (Morre et al., 2000). Human herpesviruses 
have been proposed as potential initiators of arterial injury. This 
theory was based on the results of studies using animal model (Minick 
et al., 1979), the epidemiological association between herpes viral 
infection and accelerated arteriosclerosis in heart transplant patients 
and in restenosis after angioplasty (Cunningham et al., 1988; Melnick 
et al., 1995; Hajjar et al., 1991; Visser et al., 1993).  
Eight members of the family Herpesviridae are now known to infect 
humans (Frenkel et al., 1990). Herpes simplex virus type 1 (HSV-1), 
herpes simplex virus type 2 (HSV-2), Epstein-Barr virus (EBV) and 
cytomegalovirus (CMV) are widespread in the general population. 
Therefore, these viruses can be primary candidates related to 
atherosclerosis for investigations. In 1983, Benditt et al. reported the 
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presence of herpes simplex virus (HSV) mRNA in specimens of aortic 
wall removed from patients undergoing coronary bypass surgery. 
Presence of HSV genome was demonstrated by in situ hybridization in 
13 aortic specimens, some of which appeared to represent early stages 
of atherosclerosis. Cytomegalovirus (CMV) or Epstein-Barr virus 
(EBV) genome was not detected in any of the specimens examined. It 
was also demonstrated that HSV type 1 (HSV-1) is capable of 
proliferating in cultured human fetal aortic smooth muscle cells. 
Benditt et al. (1983) postulated that expression of at least a part of the 
herpesvirus genome in arterial smooth muscle cells may in some cases 
be instrumental in initiating or maintaining the enhanced cell 
proliferation observed in the pathogenesis of atherosclerosis. 
Cytomegalovirus, a beta-herpesvirus, infection is characterized by a 
primary infection leading to a lifelong persistence of the viral genome. 
Periodically, the virus reactivates from latency and recovers its ability 
to multiply. It has been associated with the development of accelerated 
arteriosclerosis and increased graft rejection in heart transplant 
recipients (Fryd et al., 1980; Peterson et al., 1980; Grattan et al., 
1989; Light et al., 1979; Cameron et al., 1989). Both direct infection 
of the aorta and coronary arteries by CMV, and indirect activation of 
the host immune system by CMV have been proposed (Grattan et al., 
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1989). 
The purpose of this study was to examine the aorta and coronary 
arteries of subjects with atherosclerosis for the presence of CMV, and 
to evaluate the relationship between cytomegalovirus and 
atherosclerosis. This study employed two methods, in situ 
hybridization and polymerase chain reaction (PCR). In situ 
hybridization was employed because this technique has been shown to 
be sensitive in detecting CMV in vessels and it provides topological 
information as to the distribution of viral nucleic acids (Petrie et al., 
1987; Yamashiroya et al., 1988). In addition to CMV, the presence of 
Chlamydia pneumoniae and Helicobacter pylori was also investigated 
to test the possible relationship of these infectious microorganisms to 
the pathogenesis of atherosclerosis. 
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Figure I-1.  Atherosclerosis of the coronary artery and aorta. 
Panel A, B, and D, gross pictures of coronary artery and aorta; Panel C 
and E, hematoxylin-eosin stain. 
A
× 100 × 100
C
E
B
D
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II. MATERIALS AND METHODS 
 
Materials  
The study population consisted of 23 persons (15 men and 8 
women; range of age, 21-65 years; mean age, 43 years) with 
atherosclerotic aorta and coronary artery, who were all referred to 
National Institute of Scientific Investigation (NISI; Seoul, Korea) for 
autopsy between April and October 2001. For control studies, aorta 
and coronary artery specimens, from which atherosclerotic lesions 
including fatty streak and plaque were excluded, were obtained from 
10 persons (6 men and 4 women; range of ages, 18-54 years; mean 
age, 36 years) who were died from traffic accidents. 
 
Tissue preparation 
Immediately following removal of aorta and coronary artery 
segments, each segment was fixed with 10% formalin in order to 
maintain vascular morphological integrity. To preserve the integrity of 
the adventitia and perivascular tissues, aorta and coronary artery 
specimens were carefully removed in a segment along with adjacent 
tissues and rinsed with PBS (phosphate buffered saline). Each 
segment was overnight processed through the following solutions: 
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serially 70%, 75%, 80%, 90%, 95% ethyl alcohol, absolute ethyl 
alcohol, acetone, 2 changes of xylene, 2 changes of paraffin by 
Hypercenter XP Tissue Processing System (Shandon Scientific 
Limited, Cheshire, England). The processed segment was embedded 
in paraffin and cut in 5 µm sections, which were stained with 
hematoxylin-eosin (H&E). One lesion from each segment, which had 
morphological characteristics of atherosclerosis ranging from fatty 
streak to complicated atherosclerosis lesion was assigned for 
histopathologic analysis and matched with the corresponding lesions 
for in situ hybridization and polymerase chain reaction. 
 
Verhoeff’s Elastic Tissue Stain 
 The elastic lamina serves as a barrier for cells and macromolecules 
between the intima and media, media and adventitia in the vascular 
wall. The morphological changes of the elastic lamina architecture in 
the atherosclerotic aorta and coronary arteries were evaluated by 
Verhoeff’s elastic tissue staining method. 
The paraffin sections (5 µm) were made and transferred to glass 
slides, and then were deparaffinized and rehydrated through the 
following solution: xylene 3 times for 3 minutes in each, and serially 
100%, 95%, 80%, 75%, and 70% ethyl alcohol for 3 minutes in each. 
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The sections were then treated with Verhoeff’s elastic tissue staining 
solution (alcoholic hematoxylin 22 ml, 10% ferric chloride 8 ml, 
iodine solution 8 ml) for 10 minutes, followed by washing in distilled 
water. The sections were differentiated in 2% ferric chloride for only a 
few minutes, checked under microscope and if differentiated too far, 
restained. The sections were then treated with 5% sodium thiosulfate 
for 1 minute. Washed in tap water for 5 minutes, and then 
counterstained in van Gieson’s staining solution (10% acid fuchsin 5 
ml, saturated aqueous solution picric acid 100 ml) for 1 minute. The 
sections were differentiated in 95% ethyl alcohol, 2 changes of 
absolute ethyl alcohol, 2 changes of xylene, and mounted. 
 
In Situ Hybridization 
Five µm thick sections of formalin fixed paraffin-embedded tissue 
(aorta, coronary artery) were floated from a bath of distilled water 
onto acid cleaned 3-aminopropyltriethoxysilane coated slides 
(ProbeOnTM plus slides, Fisher Scientific, Pittsburgh, PA, USA), and 
heated in a 60℃ incubator. The sections were then dewaxed in xylene 
2 times for 3 minutes and rehydrated in serial-graded ethanol washes 
(100%, 95%, 80%, 70%), and immersed in water for 3 minutes. The 
slides were placed on an incubation tray and digested with 100 µl of  
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proteinase K (20 µg/ml, diluted in 50 mM Tris/HCl buffer, pH 7.6), 
and incubated for 20 minutes at 37℃. The slides were immersed in 
water 2 times for 3 minutes and dehydrated again in serial-graded 
ethanol (70%, 80%, 95%, 100%) and air-dried. 
The fluorescein-labeled oligonucleotide probes hybridization 
solution for detection of human cytomegalovirus early gene mRNA 
sequences (Hyb-probeTM, Shandon Scientific Limited, Cheshire, 
England) was applied in formamide solution (50% formamide, 0.1 M 
Pipes, pH 7.8 and 0.01 M EDTA) in a volume, usually 20 µl, 
sufficient to cover the section. An acid-washed, siliconized coverslip 
was placed over the section and sealed with rubber cement. The slides 
were incubated at 65℃ for 10 minutes which improve results by a) 
inactivating endogenous alkaline phosphatase activity, thus reducing 
background and eliminating the need for levamisole, and b) removing 
any secondary structure present in the mRNA target, thus increasing 
hybridization efficiency. The slides were hybridized for 2 hours at 
37℃. After hybridization the slides were submerged in post-
hybridization solution (TBS containing 0.1% Triton X-100), allow 
coverslips to float off. The tissue sections were washed at room 
temperature with 3 changes of TBS/Triton for 3 minutes. The slides 
were placed on incubation tray and the tissue sections were covered 
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with 100 µl of blocking solution (normal rabbit serum diluted 1:5 in 
TBS containing 3% w/v bovine serum albumin and 0.1% v/v Triton 
X-100), and incubated at room temperature for 10 minutes. The 
blocking solution was tipped off and the sections were covered with 
detection antibody (rabbit F(ab’) anti-FITC, conjugated to alkaline 
phosphatase, diluted 1:200 in TBS containing 3% w/v bovine serum 
albumin and 0.1% v/v Triton X-100), and incubated at room 
temperature for 30 minutes. Non-specific binding to the specimen was 
kept at a minimum due to the use of an antibody F(ab’) fragment. The 
tissue sections were washed at room temperature with 2 changes of 
TBS for 3 minutes. The slides were immersed in alkaline phosphatase 
substrate buffer (100 mM Tris/HCl pH 9.0, 50 mM magnesium 
chloride, 100 mM sodium chloride) for 5 minutes. The slides were 
placed in incubation tray and the alkaline phosphatase activity was 
demonstrated by covering the sections with 100 µl of NBT/BCIP 
chromogen solution (80 µl nitro blue tetrazolium 75 mg/ml in 70% 
v/v dimethyl formamide, 80 µl 5-bromo-4-chloro-3-indolyl phosphate 
50 mg/ml in dimethyl formamide, 10 µl 1 M levamisole, 10 ml 
alkaline phosphatase substrate buffer), and incubated at room 
temperature in the dark overnight. The slides were washed in running 
water for 5 minutes, counterstained lightly in Nuclear Fast Red (0.1% 
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nuclear fast red, 5.0% aluminum sulfate) for a maximum of 10 
seconds, and washed in running water. Mounted with aqueous 
mountant. 
Using this technique, only minimal background hybridization was 
produced. Positive staining was recognized under the microscope as a 
blue/black color at the site of hybridization. Hybridization was 
considered positively only in those cases in which the intensity of 
hybridization was above background, and the control probes did not 
hybridize. 
 
DNA Extraction in Paraffin-Embedded Tissues 
For PCR reaction, several of 5 µm-thick sections of each paraffin 
embedded sample were put in 2.0 ml microcentrifuge tube using clean 
forceps. To deparaffinize samples, 1 ml of xylene was added and then 
inverted several times, and incubated at room temperature for 10 
minutes properly on a rocking platform. Centrifuged for 3 seconds at 
15,000 rpm in microcentrifuge to pellet the tissue, carefully decanted 
and 1 ml of xylene was added, inverted several times and incubated at 
room temperature for 10 seconds and centrifuged for 3 seconds at 
15,000 rpm. To remove remained xylene, the pellet was washed by 
adding 100% ethanol, inverted the tube two or three times, centrifuged 
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for 3 seconds at 15,000 rpm in microcentrifuge to pellet the tissue and 
decanted. The pellet was washed by adding 95% ethanol and 70% 
ethanol serially. To digest tissues, the pellet was resuspended in 600 µl 
of digestion buffer containing freshly thawed proteinase K (stock 500 
µg/ml, 10 µg/20 µl), incubated at 60℃ in water bath with shaking for 
overnight. 
To extract the DNA, the tubes were centrifuged lightly for 5 
seconds, 200 µl of supernatant was put into new tube, 150 µl of 
saturated phenol and 150 µl of chloroform-isoamylalcohol (24:1) were 
added, vortexed vigorously for 15 seconds, and centrifuged for 5 
minutes at 13,000 rpm. The upper phase was put into new tube, 
repeated upper process (150 µl of saturated phenol and 150 µl of 
chloroform-isoamylalcohol (24:1) were added, vortexed vigorously 
for 15 seconds, and centrifuged for 5 minutes at 13,000 rpm). The 
upper phase was put into new tube. To remove phenol, 150 µl of 
chloroform-isoamylalcohol (24:1) was added, vortexed vigorously for 
15 seconds, and centrifuged for 5 minutes at 13,000 rpm. The upper 
phase was put into new tube. Two volume of absolute ethanol and 
1/10 volume of 0.3 M sodium acetate were added to new tube, 
inverted several times, placed at –20℃ for 2 hours. Centrifuged at 
4℃ in 13,000 rpm for 30 minutes, removed the supernatant carefully. 
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One ml of 70% ethanol was added for washing of DNA pellet, 
centrifuged in 13,000 rpm for 15 minutes at 4℃, twice. The pellet was 
dried at 56℃ for 10 minutes. 20 µl of distilled water was added and 
stored at -20℃ until used. 
 
Oligonucleotide Synthesis 
Oligonucleotides were purchased from the Bioneer corporation 
(Cheongwon, Korea) at a scale of 50 ~ 200 nmoles. Oligonucleotides 
were purified by denaturing polyacrylamide gel electrophoresis using 
8 ~ 12% acrylamide/ 8 M urea gels and desalted by passage over a 
Waters Sep-Pack cartridge or Pharmacia NAP-25 column as described 
elsewhere (Table I-1) (Sambrook et al., 1989).  
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Table I-1.  Sequences of primers for the detection of HSV-1, CMV, 
HHV6, EBV, C. pneumoniae and H. pylori 
   
Sequence   Target gene    Amplicon       
Reference 
(5’→3’)    (Location)    length (bp) 
   
HSV-1 DNA Polymerase gene   McGeoch et al., 
Sense: TCC TCG TAG ACG CCC ATC GGC G        65884-65865      134          1986 
Antisense: CTT GTA ATA CAC CGT CAG GT         65977-65958 
 
CMV  major immediately-early gene   Horvath et al., 
Sense: CCT AGT GTG GAT GAC CTA CGG GCC A    171362-171386   249          2000 
Antisense: CAG ACA CAG TGT CCT CCC GCT CCT C 171137-171161 
 
HHV6  immediately-early gene    Horvath et al., 
Sense: CCG CAA TCG AAT CCA CCT AGC GG         47254-47277    435          2000 
Antisense:GTG AGA ACG GAT TCG AAC AGT GCT G  47665-47689 
 
EBV    BamH-IW region gene       Saito et al., 
Sense: CCT AGG GGA GAC CGA AGT AA            14554-14573     234          1989 
Antisense: GAC CCT TCT ACG GAC TCG TCT G      14787-14766 
 
C. pneumoniae    16S rRNA gene   Charlotte et al., 
Sense: TGA CAA CTG TAG AAA TAC AGC           8362-8382        463          1992 
Antisense: CGC CTC TCT CCT ATA AAT             8809-8826 
 
H. pylori    urease gene    Clayton et al., 
Sense: GCC AAT GGT AAA TTA GTT            2236-2253        411          1992 
Antisense:CTC CTT AAT TGT TTT TAC            1843-1860 
  
HSV-1, herpes simplex virus type 1; CMV, cytomegalovirus; EBV, Epstein-Barr 
virus; HHV6, human herpes virus 6; C. pneumoniae, Chlamydia pneumoniae; 
H. pylori, Helicobacter pylori 
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Polymerase Chain Reaction (PCR) 
According to the published DNA sequences, specific primers that 
amplify corresponding target gene regions were synthesized (HSV-1: 
DNA polymerase gene, McGeoch et al., 1986; EBV: BamH-IW region 
gene, Saito et al., 1989; CMV: major immediately-early gene, Horvath 
et al., 2000; HHV6: immediately-early gene, Horvath et al., 2000; C. 
pneumoniae: 16S rRNA gene, Charlotte et al., 1992; H. pylori: urease 
gene Clayton et al., 1992), all of which were expected to be highly 
conserved (Table 1). All DNA isolates were tested for the presence of 
PCR inhibitors and for the human DNA isolation efficiency by the 
control amplification of the 540 bp long target of human beta-actin 
gene with primers sense (5’ GTG GGG CGC CCC AGG CAC CAG 
GGC 3’) and antisense (5’ CTC CTT AAT GTC ACG CAC GAT TTC 
3’). The specificity of the oligonucleotide sequence was initially 
determined by a GenEMBL database search with the FastA algorithm, 
which showed 100% homology with the target gene and minimal 
homology with non-specific mammalian gene sequences. 
PCR reaction mixtures contained 2 µl template DNA, 2 µl 10× 
buffer, 1.2 µl MgCl2 (at a final concentration of 1.5 mM), 1.6 µl 
dNTPs (0.2 mM), 2 µl each primer (Table 1) at 2 pmol/µl, and 1.25 U 
of thermostable Taq polymerase (Takara shuzo, Kyoto, Japan). The 
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final volume was filled to 20 µl with sterile distilled water. The 
amplification reaction was performed on a thermal cycler (Perkin 
Elmer 9600, Norwalk, CT, USA). The cycle parameters were as 
follows: first cycle of 94℃ for 3 minutes to initial denaturation; 34 
subsequent cycles of 95℃ for 1 minute, 58℃ for 2 minutes, 72℃ 
for 1 minutes; final cycle of 72℃ for 7 minutes to enough extension. 
Five microliters of the amplification products were subjected to 
electrophoresis on 1.5% agarose gels (NuSieve GTG agarose; BMA, 
Rockland, ME, USA) at 100 V for 20 minutes. The gels were stained 
with ethidium bromide for 30 minutes. Gels were observed, 
photographed and data stored in a computer by Gel Documentation 
Systems Gel Doc2002 (Bio-Rad Laboratories, Hercules, CA, USA). 
 
Sequencing of PCR products 
 The PCR product was sequenced using ABI 377 DNA sequencer 
with ABI PRISM BigDye Terminator Cycle Sequencing Kit (PE 
Applied Biosystems, Foster, CA, USA). For each reaction the 
following reagents were added to a separate tube: 8.0 µl of Terminator 
ready reaction mix, 5 µl of PCR products (200-500 ng), 4 µl of each 
of primer (3.2 pmol), and deionized water (3 µl) to total volume of 20 
µl. Cycle sequencing on the GeneAmp 9600 (Perkin Elmer, Norwalk, 
CT, USA): the tube was placed in a thermal cycler and repeated the 
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following for 25 cycles; 96℃ for 10 sec, 50℃ for 5 sec, 60℃ for 4 
min. Rapid thermal ramp to 4℃ and holded until ready to purify. The 
entire contents of each extension reaction was put into a 1.5 ml 
microcentrifuge tube and 60 µl of 100% isopropanol and 20 µl of 
distilled water were added. The final isopropanol concentration was 
about 60% (v/v). The tube was vortexed briefly and leaved at room 
temperature for 15 min to precipitate the extension products. 
Microcentrifuged for 20 min at maximum speed, the supernatants was 
aspirated carefully, to rinsing, 250 µl of 75% isopropanol was added 
and vortexd briefly. Microcentrifuged again and the samples were 
dried in a thermal cycler at 90℃ for 1 min. Each pellet was 
resuspended in 6 µl of loading buffer (5 parts deionized formamide 
and 1 part 25 mM EDTA with blue dextran (50 mg/ml). The samples 
were vortexed and spun, then the samples were heated at 95℃ for 2 
min to denature. Placed on ice until ready to load. To prepare 5% 
polyacrylamide gel, 20 g of urea was dissolved in 13.5 ml distilled 
water at 56℃ for 30 min. 4 ml of 50% Long Ranger acrylamide stock 
solution (FMC Bioproducts; Rockland, MA, USA) and 0.5 g of 
Amberlite were added, stirred gently for 5 min, then filtered and 
degassed by vacuum. Eight ml of 5× TBE was added and distilled 
water upto total 40 ml. Fifteen µl TEMED and 250 µl of 10% 
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ammonium persulfate (APS) were added. Gel solution was poured and 
polymerization for 2 hours. Samples were loaded in 1.5 µl per well 
and electrophored according to the manufacturer’s instruction. The 
sequence was analyzed and determined. 
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III. RESULTS  
 
Histopathologic Analysis 
Sections of aorta and coronary artery from control groups showed 
no histopathologic evidence of atherosclerosis except minimal intimal 
thickening. 
Compared to controls, all atherosclerotic aorta and coronary artery 
showed lesions that ranged from fatty streak to complicated 
atherosclerotic plaque. There was also prominent inflammatory 
infiltration of mononuclear cells and foam cells in atherosclerotic 
plaque, and to a lesser extent in the inner media and adventitia. 
 
Verhoeff’s Elastic Tissue Stain 
Verhoeff’s elastic tissue stain of the vessels from control group 
revealed smooth and regular pattern of elastic lamina without 
disruption of its structure (Figure I-2, A-C; Figure I-3, A-C). 
Conversely, the elastic lamina from atherosclerotic sections revealed 
an altered pattern characterized by fragmentation and disorganization 
of the elastic lamina associated with an increase in the thickness 
(Figure I-2, D-F; Figure I-3, D-F).  
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Figure I-2.  Verhoeff’s elastic fiber stain of the elastic lamina in 
aorta. The structure of the elastic lamina in normal aorta (panel A-C), 
and atherosclerotic aorta (panel D-F). Atherosclerotic aorta revealed 
the elastic lamina was fragmented and disorganized (arrow in panel F). 
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F
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Figure I-3.  Verhoeff’s elastic fiber stain of the elastic lamina in 
coronary artery. The structure of the elastic lamina in normal 
coronary artery(panel A-C), and atherosclerotic coronary artery 
(panel D-F). Atherosclerotic coronary artery revealed the elastic 
lamina was fragmented and disorganized (arrow in panel F). 
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In Situ Hybridization 
Of 23 subjects with atherosclerosis, CMV was detected by in situ 
hybridization in 60.9% (14/23) of aorta and 42.9% (9/21) of coronary 
arteries. Of 10 control subjects, CMV was detected in only one 
coronary artery (Table I-2).  
By in situ hybridization, CMV was localized in cells 
morphologically consistent with endothelial cells, smooth muscle cells, 
lymphocytes, fibroblasts, and Schwann cells. CMV was sometimes 
detected in spindle-shaped cells located in discrete foci of increased 
cellularity (shoulder region) within the intima. CMV was detected 
more frequently in atherosclerotic areas than in non-atherosclerotic 
areas (Figure I-4 and I-5). 
Atheromatous changes consisted of focal or eccentric intimal 
thickening with smooth muscle cell proliferation and the presence of 
lymphocytic infiltrates and/or scattered foam cells. CMV was found 
in the aorta in 14 of 23 subjects. Of 14 positive subjects, 9 showed 
mild atheromatous changes, and 5 showed moderate atheromatous 
changes (Table I-3). T-lymphocytic infiltrates were evident in the 
intima of all 14 cases. CMV genome or antigen was found in the 
coronary arteries in 9 of 21 subjects. Of 9 positive subjects, 4 showed 
mild atheromatous changes and 5 showed moderate atheromatous 
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changes (Table I-4).  
This study shows evidence for the presence of CMV in the 
coronary arteries and aorta of Korean by in situ hybridization method. 
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Table I-2.  Detection of CMV in aorta and coronary artery 
by in situ hybridization 
   
Control    Atherosclerosis 
Sample site 
Cases   Positive cases  Cases Positive cases 
   
Aorta               10 0 23     14 
 
Coronary artery       10  1 21      9  
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Figure I-4.  Atherosclerotic lesions showing the presence of CMV 
in intimal cells by in situ hybridization. Panel A-B, hybridization 
was seen in aorta (arrow in panel B); Panel C-D, hybridization was 
seen in coronary artery (arrow in panel D). 
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Figure I-5.  Atherosclerotic lesions showing the presence of CMV 
by in situ hybridization (×200). Panel A, hybridization with CMV 
probe was seen in intimal cells; panel B, smooth muscle cells (SMCs); 
panel C, vascular endothelial cells in adventitia; panel D, Schwann 
cells (arrow in panels). 
A B
C D
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Table I-3.  Relationship between degree of atherosclerosis and 
CMV detection in the aorta 
   
Degree of Atherosclerosis  Cases      Positive cases 
   
Mild                            15      9 
Moderate                         7       5 
Severe                           1       0 
 
Total      23      14  
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Table I-4.  Relationship between degree of atherosclerosis and 
CMV detection in the coronary arteries 
   
Degree of Atherosclerosis      Cases      Positive cases 
   
Mild 8      4 
Moderate 12      5 
Severe 1      0 
 
Total    21      9  
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PCR amplification of CMV in aorta and coronary artery 
The viral nucleic acid of herpes simplex virus type 1 (HSV-1), 
cytomegalovirus (CMV), human herpes virus 6 (HHV6), Epstein-Barr 
virus (EBV), Chlamydia pneumoniae, Helicobacter pylori was studied 
by polymerase chain reaction (PCR) in aorta and coronary arteries 
from 23 autopsy cases.  
Of 23 subjects with atherosclerosis, CMV was detected by PCR in 
65.2% (15/23) of aorta and 52.4%(11/21) of coronary arteries, and in 
3 of aorta and coronary arteries in 10 control subjects (Figure I-6 and 
I-7) (Table I-5). 
Positive results were detected in 8.7% (2/23) for HSV-1, 4.3% 
(1/23) for EBV, 43.5% (10/23) for Chlamydia pneumoniae, but HHV6 
and Helicobacter pylori were not detected. Despite of the high genetic 
and biological similarity between CMV and HHV6, no substantial 
relation of HHV6 in atherosclerosis has been proved. In the 
atherosclerotic group, DNA of two or three viruses was noted several 
times in a single sample, whereas neither double nor triple infections 
occurred in the control group. These finding confirm and extend those 
of Benditt et al. (1983) and Melnick et al. (1995) of the presence of 
herpesviruses not only in the proximal aorta but also in the coronary 
arteries of human subjects. CMV and C. pneumoniae were 
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encountered more frequently than HSV-1, EBV in both sample sites. 
CMV was detected more frequently by PCR, compared with direct 
antigen detection with fluorescein-labeled oligonucleotide probes by 
the in situ hybridization method. The lower prevalence of viruses 
detected in the same tissues by in situ hybridization (ISH) may be in 
part due to low virus levels in the infected cells and the relative 
insensitivity of ISH compared with the very sensitive method of PCR. 
In conclusion, this study suggests that the high incidences and 
kinds of herpes viruses are related to atherosclerosis. 
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Figure I-6.  Amplification of major immediately early (IE) gene 
of CMV by PCR in aorta specimens. Lane M, 100 bp and 50 bp 
ladder marker; lanes 1-4, control aorta; lanes 5-27, atherosclerotic 
aorta specimens from autopsy; P, positive control (AD-169); N, 
negative control. 
M     1     2 3     4 5     6  7      8     9  10   11   12  13  P N  M
M  14   15    16   17   18   19   20    21   22   23   24   25    26   27 N     M
249bp
249bp
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Figure I-7.  Amplification of major immediately early (IE) gene 
of CMV by PCR in coronary artery specimens. Lane M, 100 bp 
ladder marker; lanes 1-4, control coronary artery; lanes 5-25, 
atherosclerotic coronary artery specimens from autopsy; P, positive 
control (AD-169); N, negative control. 
M     1     2 3     4 5     6  7     8     9  10 11   12   13  P N    M
M    14    15    16    17    18   19    20    21    22    23    24 25    P    N    M
249bp
249bp
  35
 
 
 
 
 
Table I-5.  Detection of CMV in aorta and coronary artery 
by polymerase chain reaction (PCR) 
   
Control    Atherosclerosis 
Sample site 
Cases Positive cases Cases Positive cases 
   
Aorta             10 2        23        15  
 
Coronary artery     10  1        21         11  
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Specificity and Sensitivity of PCR 
The specificity of the six primer sets to amplify specific target gene 
was tested by amplification of DNA from herpes simplex virus type 1 
(HSV-1), cytomegalovirus (CMV), human herpes virus 6 (HHV6), 
Epstein-Barr virus (EBV), Chlamydia pneumoniae, Helicobacter 
pylori. Nonspecific amplifications were not obtained, nor was any 
interassay cross amplification observed. Assay sensitivity was 
determined by amplification of extracted DNA from duplicates of 
serial 10-fold dilutions of CMV (AD-169) 50% tissue culture 
infectious dose (TCID50) stock (AD-169 stock titer: 5×105.75 
TCID50/ml). Amplified products detected by agarose gel 
electrophoresis were observed at various dilutions and corresponded 
to a calculated minimal amount of detectable virus DNA of 2.8 
TCID50/ml for CMV (Figure I-8).  
Positive control DNA was extracted from MRC-5 human 
embryonic lung monolayer cultures infected with American Type 
Culture Collection (ATCC; VR-538) reference strains of CMV (AD-
169). 
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Figure I-8.  Sensitivity of CMV PCR. 
Lane M, 100 bp ladder marker; lane S, CMV (AD-169) stock 
(starting titer: 5×105.75 TCID50/ml); lanes 1-7, serial 10-fold 
dilutions of CMV 50% tissue culture infectious dose (TCID50) 
stock. 
M     S     1     2     3     4     5     6     7     M
249bp 
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Figure I-9.  Amplification of HSV-1, CMV, HHV6, EBV, C. 
pneumoniae, and H. pylori by PCR. Lane M, 100 bp ladder marker; 
lane 1, herpes simplex virus type 1 (HSV-1); lane 2, cytomegalovirus 
(CMV); lane 3, human herpes virus 6 (HHV6); lane 4, Epstein-Barr 
virus (EBV); lane 5, Chlamydia pneumoniae; lane 6, Helicobacter 
pylori.  
M   1     2 3     4  5     6  N    M
249 bp 
beta-actin 
(540 bp) 
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Sequencing of PCR products 
Sequence analysis revealed that PCR products extracted from 
atherosclerotic lesions using CMV-specific primer sets were indeed 
cytomegalovirus DNA of family Herpesviridae (Figure I-10). 
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Figure I-10.  DNA sequencing result of PCR product (249 bp). 
 
 
DNA Sequence of PCR products(249 bp)
1    CAGA  CACAGTGTCC  TCCCGCTCCT
41    CCTGAGCACC  CTCCTCCTCT TCCTCATCAC  TCTGCTCACT
81 TTCTTCCTGA  TCACTGTTCT  CAGCCACAAT  TACTGAGGAC
121  AGAGGGATAG  TCGCGGGTAC  AGGGGACTCT  GGGGGTGACA
161  CCAGAGAATC  AGAGGAGCTG  ACACCAGCGG  TGGCCAAAGT
201  GTAGGCTACA  ATAGCCTCTT  CCTCATCTGA  CTCCTCGGCG
241  ATGGCCCGTA  GGTCATCCAC  ACTAGG
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IV. DISCUSSION 
The possible role of herpesviruses in human atherosclerosis has 
been implicated in several studies. Because vascular smooth muscle 
cells can be transformed in vitro by HSV-2 (Nachtigal et al., 1990), it 
was hypothesized that herpesvirus-induced transformation may 
contribute to periods of uncontrolled growth in the atherosclerotic 
vessel wall. Whether the vessel wall actually contains transformed 
cells that are part of the foam cell population in atherosclerotic plaque 
regions remains unproven, however. Cunningham and Pasternak 
(1998) stressed the potential role of viruses in the pathogenesis of 
atherosclerosis and proposed a viral cause hypothesis. Extensive 
studies have revealed the importance of viruses, particularly 
herpesviruses, in atherosclerosis. In another PCR study, 90% of the 
samples obtained from patients with grade III atherosclerosis 
contained CMV viral nucleic acids, whereas only 53% of patients with 
grade I atherosclerosis contained these CMV nucleic acids (Hendrix et 
al., 1990). CMV DNA was apparently widely distributed throughout 
the arterial trees (Hendrix et al., 1991). The above findings support the 
thesis of Melnick et al. (1983) that the artery wall may be a site of 
latent CMV and possibly HSV. 
In this study, in situ hybridization was chosen to investigate the 
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possible presence of CMV in human aorta and coronary artery. In situ 
hybridization was used because this technique has been shown to be 
more sensitive than immunoperoxidase techniques in detecting 
herpesviruses in vessels. The fluorescein-labeled oligonucleotide 
probes for detection of human cytomegalovirus immediate early (IE) 
gene mRNA sequences was chosen because it has been shown to 
hybridize with the full spectrum of clinical isolates of CMV from 
humans, it lacks homology with other viruses, and it has minimal 
homology with human placental DNA (Ambinder et al., 1987), and it 
has been suggested that the IE gene is expressed in latent infections 
(Rice et al., 1984). Although homology between human and 
herpesviral sequences has been described, the probes used here are not 
reactive with control human tissues by in situ hybridization. 
 In present study, the elastic lamina from atherosclerotic sections 
revealed an altered pattern characterized by fragmentation and 
disorganization of the elastic lamina associated with an increase in 
thickness. Several studies have demonstrated discontinuities and 
abnormalities in the elastic lamina structure of elastic and muscular 
arteries during advanced atherosclerosis (Nakatake et al., 1985; Sims 
et al., 1985; Nakatake et al., 1987; Roach et al., 1988; Martin et al., 
1989; Sims et al., 1989; Rekhter et al., 1991). It has been 
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hypothesized that structural defects in the elastic lamina may play an 
important role during the formation of an atherosclerotic lesion, 
allowing cell migration and macromolecule transfer between the 
intima and different layers of the vascular wall (Sims et al., 1985; 
Sims et al., 1989). This elastic lamina changes may be associated with 
the neoadventitial formation and phenotypic change of myofibroblasts. 
The arterial wall is an integrated functional component of the 
circulatory system that is continually remodeling in response to 
hemodynamic conditions and disease states. The disruption of elastin 
is enough to facilitate the migration of myofibroblasts and the 
proliferation of smooth muscle. Thus, elastin is a molecular 
determinant of arterial morphogenesis such as vascular remodeling, 
stabilizing arterial structure by regulating proliferation and 
reorganization of vascular smooth muscle (Li et al., 1998). The 
decrease in the percentage of elastin content in the elastic lamina was 
associated elastolytic activity. Contrary to collagen, elastin has an 
extremely long half-life (40-70 years). Loss of elastin is almost 
certainly a manifestation of excessive elastolysis rather than 
insufficient synthesis. This study suggests that structural changes of 
elastic lamina may play an important role in the development of 
atherosclerotic matrix reorganization, resulting in vascular remodeling.  
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In animal models of virus-induced atherosclerosis, herpesviruses 
have been demonstrated in endothelial cells, smooth muscle cells and 
lymphocytes  (Gyorkey et al., 1984; Hendrix et al., 1991; Gnann et 
al., 1988). These are the same cell types to which this study found 
hybridization of CMV probes. Hybridization to cells without inclusion 
bodies or cytopathic effects suggests that the CMV present in these 
vessels is in a latent state. 
In addition, there is some suggestive evidence that CMV may be 
important as a cofactor in the development of atherosclerosis. This 
evidence comes from animal models and patient studies. In chickens, 
Fabricant et al. (1978, 1981) and Minick et al. (1979) demonstrated 
that infection with Marek’s disease virus (MDV) leads to occlusive 
atherosclerosis in large muscular arteries. The atherosclerosis induced 
by MDV closely resembles that in humans and occurs in both 
normocholesterolemic and hypercholesterolemic chickens. 
CMV infection may promote the development of atherosclerosis in 
human through a number of direct and indirect mechanisms (Grattan 
et al., 1989). CMV infection could directly injure endothelial cells, 
and the response to this injury could promote the development of 
arteriosclerosis as described by Ross et al. (1990). More subtle forms 
of viral-induced endothelial injury could also promote arteriosclerosis 
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by reducing the anticoagulant properties of endothelial cells (Visser et 
al., 1988; Etingin et al., 1990). 
CMV infection has also been associated with an upregulation of 
major histocompatibility (MHC) antigen expression by endothelial 
and smooth muscle cells (van Esa et al., 1984; von Willebrand et al., 
1986; Hosenpud et al., 1991). Upregulation of MHC antigen 
expression is presumably mediated by the release of γ-interferon by 
activated T-lymphocytes responding to the CMV infection. The 
induced MHC antigen expression is itself associated with allograft 
rejection and the development of accelerated arteriosclerosis (Hruban 
et al., 1990). An immune response generated by the recipient against 
viral proteins could lead to a heightened response to donor MHC 
antigens and thus further promote allograft rejection and the 
development of accelerated arteriosclerosis (Fujinami et al., 1988). 
CMV infection of smooth muscle cells could also promote 
accelerated arteriosclerosis. For example, the infection of arterial 
smooth muscle cells with MDV alters lipid metabolism and results in 
enhanced lipid accumulation in these cells (Fabricant et al., 1981; 
Minick et al., 1979; Hajjar et al., 1986). CMV may promote 
atherosclerosis by inducing the proliferation of smooth muscle cells 
(Benditt et al., 1976). In addition to smooth muscle and endothelial 
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cells, CMV infection of lymphocytes has also been demonstrated 
(Rice et al., 1984; Schrier et al., 1985). CMV infection of 
lymphocytes may activate lymphocytes and this activation of 
lymphocytes may promote graft rejection and the development of 
accelerated arteriosclerosis (van Esa et al., 1984). 
Melnick et al. (1983) demonstrated by immunofluorescence tests 
the presence of CMV antigen in smooth muscle cells cultured from 
arterial tissues of patients undergoing blood vessel surgery. More than 
25% of the cell cultures of arterial tissues derived from both carotid 
artery plaques and punch biopsy samples of uninvolved areas of the 
aorta were reported to contain antigens of CMV but not of HSV-1 or 
HSV-2. Replicating CMV was not detected by electron microscopy in 
the antigen-positive cells, and it was suggested that the artery wall 
may be a site of CMV latency. In 1984, Gyorkey et al. reported the 
presence of virions of the herpesviridae family on direct electron 
microscopic examination of punch biopsy specimens from the 
proximal aorta of patients with atherosclerosis. Herpes-type virions 
were detected in occasional smooth muscle and rare endothelial cells 
in uninvolved areas of the aorta in 10 of 60 patients examined. Petrie 
et al. (1987) reported the presence of nucleic acid sequences of CMV 
in cells cultured from human arterial tissue, thus extending the earlier 
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findings by Melnick et al. (1983) of CMV antigen detection in 
cultured arterial cells. 
The identification of CMV in the arterial tissues is of epidemiologic 
interest because of the high prevalence of primary infection with this 
virus in peoples. In disseminated CMV infection local viral spread is 
believed to occur via endothelial cell infection (Myerson et al., 1984). 
Whether the presence of CMV in the coronary arteries and aorta 
represents primary infection with hematogenous spread to lesion 
predilection sites or secondary seeding following reactivation of latent 
infection at a distant site remains to be established. 
The mere presence of herpesviruses in the arterial wall does not 
necessarily signify a causal relationship to atherosclerosis. However, 
CMV could play a significant role in the initiation or progression of 
human atherosclerosis by several mechanisms, depending on the 
particular cell type involved and whether the infection is permissive or 
nonpermissive. Productive infection in permissive cells may result in 
alterations of aortic lipid metabolism and/or direct injury of 
endothelial or intimal cells. In Marek’s disease virus infection of 
chicken, lipid metabolism has been shown to be altered with 
significant accumulation of cholesterol and cholesteryl esters in 
infected aortic smooth muscle cells (Fabricant et al., 1981; Hajjar et 
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al., 1986). CMV-infected human fetal aortic cells have also been 
reported to proliferate and accumulate cholesterol in vitro (Hajjar et 
al., 1986). CMV has also been shown to replicate in smooth muscle 
cell cultures derived from human umbilical arteries (Tumilowicz et al., 
1985). CMV can infect endothelial cells in vivo, in support of the 
concept that endothelial cell integrity may play an important role in 
the initial stages of atherogenesis. 
Immunologic injury as a consequence of productive or lytic 
infection with CMV may also play a role in atherogenesis. In 1974, 
Smith et al. reported the presence of measles and herpesvirus antigen-
antibody complexes in aorta from autopsy cases and postulated that a 
significant cause of vascular tissue injury in humans may be chronic 
viral infection of the blood vessels per se and/or the deposition of 
antigen-antibody complexes in the vascular tissues. Several human 
viruses, including CMV, have been shown to induce formation of Fc 
receptors in a variety of cultured cells (Westmoreland et al., 1976; 
Sakuma et al., 1977). Whether Fc and C3 receptor are induced in 
arterial endothelial and smooth muscle cells in vivo by CMV remains 
to be established. 
In addition to lytic infection, latency or persistence, or less 
frequently, acquisition of a transformed phenotype are pathogenic 
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features of human herpesvirus infection (Tevethia et al., 1985). 
Benditt et al. (1983) have suggested that expression of at least a part 
of the herpesvirus genome in arterial smooth muscle cells may initiate 
or maintain enhanced smooth muscle cell proliferation leading to 
monotypic atheromatous plaque formation. Penn et al. (1986) 
demonstrated that plaque cells exhibit molecular alterations similar to 
that observed in oncogenic transformation and have proposed that one 
or more unidentified transforming genes may play a role in the 
proliferation of smooth muscle cells in atherogenesis. Of obvious 
interest in this regard is CMV infection of arterial tissues that induce 
somatic cell gene alterations leading to smooth muscle cell 
proliferation and atherosclerotic plaque development. 
Many of the important cellular effects of CMV were derived from 
expression of its immediate-early (IE) gene products in the absence of 
early and late gene expression and of viral replication. In this type of 
infection, called an abortive infection, death of the host cell does not 
occur. It is likely that abortive infections are of biological relevance, 
providing a mechanism whereby intracellular pathogens contribute to 
disease progression. One molecular mechanism by which CMV may 
increase cellular proliferation is through inhibition of the tumor 
suppressor gene, p53; the p53 gene product inhibits cell cycle 
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progression (Levine et al., 1997) and therefore cell proliferation 
(Yonemitsu et al., 1998). IE2-94, 1 of the IE gene products of CMV, is 
capable of binding to p53 and inhibiting its transcriptional activity 
(Speir et al., 1994; Tsai et al., 1996). Another mechanism by which 
CMV infection could lead to cellular proliferation is stimulating the 
secretion of growth factors or increasing the expression of growth 
factor receptors. CMV infection of smooth muscle cells has recently 
been shown to increase PDGF receptor expression (Zhou et al., 1999). 
CMV infection inhibits apoptosis in human endothelial cells (Kovacs 
et al., 1996), an effect caused at least partly by the IE gene products of 
the virus (Zhu et al., 1995). One of the mechanisms by which this 
occurs is probably inhibition of the p53-modulated apoptotic program 
(Levine et al., 1997). 
The histopathologic findings in this study may indicate that CMV 
infections are associated mainly with areas showing early or advanced 
atheromatous changes in the coronary arteries and with lesion areas in 
the aorta. Microscopically, lymphocytic infiltrates were evident in 
both sites in the majority of virus-positive cases with early or 
advanced atheromatous changes. Emeson et al. (1986) have 
demonstrated mononuclear cell infiltrates in the coronary arteries and 
aorta, and have identified some of the inflammatory cells as T-cell 
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subsets and monocytes/macrophages. CMV has been shown to 
abortively infect peripheral human lymphocytes of T- and B-cells 
lineage and monocytes with virus expression limited to synthesis of 
immediate-early viral polypeptides (Rice et al., 1984). Macrophages 
may be recruited to the plaque causing weakening of the fibrous cap 
and subsequent plaque rupture (Kol et al., 1998). 
This study found the presence of CMV genome significantly more 
often in the atherosclerotic group than in the non-atherosclerotic group. 
In the atherosclerotic group, the DNA of either two or three viruses 
was noted in a single sample. These present results indicate that only 
atherosclerotic tissues are likely to contain multiple infectious agents. 
More recent studies have suggested that the impact of infection on 
atherogenesis is related to the aggregate number of pathogens with 
which an individual is infected, a concept referred to as pathogen 
burden (Zhu et al., 2000; Rupprecht et al., 2001). 
In the present study, the results may simply represent one potential 
means of arterial injury, and are compatible with the aforementioned 
response to injury hypothesis. At the least, this study data suggest that 
viral infections might promote atherosclerosis, perhaps by increased 
expression of adhesion molecules and inflammatory cytokines 
(Grundy et al., 1993; Span et al., 1991), procoagulant effects (Etingin 
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et al., 1990), increased scavenger receptor expression and activity 
(Zhou et al., 1996), enhanced uptake of cholesterol and of modified 
low-density lipoprotein (Hajjar et al., 1986), increased smooth muscle 
cell migration and proliferation (Zhou et al., 1999), anti-apoptotic 
effects (Tanaka et al., 1999) and autoimmune response to infection 
(Epstein et al., 2000). 
The pathway for the delivery of these viruses to the arterial wall has 
not yet been identified. It is possible that these and other pathogens 
directly infect the vessel wall and persist in a latent state, either 
producing an abortive infection or replicating at a low (and possibly 
intermittent) level. An alternative possibility focuses on the circulating 
monocyte as a ‘Trojan horse’, a vehicle for the delivery of the 
pathogen to the vessel wall (Epstein et al., 1999). 
Other microorganisms, such as Chlamydia pneumoniae (Davidson 
et al., 1998; Yamashita et al., 1998; Kuo et al., 1997; Grayston et al., 
1995) and Helicobacter pylori (Ossei-Gerning et al., 1997; Birmie et 
al., 1998; Hoffmeister et al., 2001; Markus et al., 1998), are also 
related to atherosclerosis. The fact that multiple pathogens have been 
associated with atherosclerosis implies that many ‘atherogenic’ 
pathogens exist. It is also evident that variability exists in host 
susceptibility to the atherogenic effects of pathogens. The lack of 
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unique or specific pathogens for atherosclerosis does not deny the 
causal role of infectious pathogens; this depends on the susceptibility 
of the host.  
In conclusion, this study demonstrates that CMV genome and 
antigen is commonly present in the aorta and coronary arteries of 
Korean by in situ hybridization and PCR methods. The availability of 
fresh autopsy tissues from Korean provided a unique opportunity to 
determine the presence and expression of these ubiquitous viruses in 
human atherosclerotic lesions. The virologic and histopathologic 
findings presented in this study further substantiate the possible role of 
cytomegalovirus in the pathogenesis of human atherosclerosis. 
Because atherosclerosis is a multifactorial disease, the relationship of 
these findings to epidemiologic features such as age, sex, race, and 
other risk factors will be assessed in an expanded study population as 
part of a multicenter study.  
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CHAPTER II 
 
 
 
Coexpression of Cyclooxygenase-2 and Matrix 
Metalloproteinase-9 in Human Atherosclerotic 
Lesions Infected by Cytomegalovirus 
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I. INTRODUCTION 
 
 Atherosclerosis is currently considered to be an exaggerated 
response of the vessel wall to injury characterized by inflammation 
and fibrocellular proliferation rather than a degenerative disease due 
to hemodynamic loading (Ross et al., 1993; Alexander et al., 1994). 
This view is supported by the demonstration of abundant macrophages 
and T-lymphocytes in atherosclerotic plaque, as well as studies 
examining markers of inflammation such as C-reactive protein 
(Jonasson et al., 1986; Ridker et al., 1997; Liuzzo et al., 1994). Plaque 
rupture leading to thrombosis is the key event in myocardial infarction 
and it has been shown to be related to increased inflammation within 
the plaque, rather than plaque morphology or degree of vessel stenosis 
(van der Wah et al., 1994). Chronic inflammatory lesions are often 
associated with a significant destruction of connective tissue. The 
association of the monocytes/macrophages with lesions where there is 
the destruction of connective tissue in atherosclerotic tissue favors 
their participation in the breakdown of collagen. 
 In addition, chronic infection and inflammation have recently 
been implicated as important etiologic agents for atherosclerosis. 
Several agents have been suggested as being responsible for chronic 
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inflammation including cytomegalovirus, Helicobacter pylori, and 
Chlamydia pneumoniae (Ridker et al., 1998; Mattila et al., 1998; Kuo 
et al., 1995). 
 The production of matrix metalloproteinases (MMPs) by human 
monocytes has been shown to occur through a prostaglandin (PG) E2-
cAMPs dependent pathway (Wahl et al., 1977; McCarthy et al., 1980; 
Wahl et al., 1987). Signaling through this pathway involves the 
modulation of prostaglandin H synthase, that is, cyclooxygenase 
(COX) (Corcoran et al., 1994). Two COX isoforms have been 
identified, referred to as COX-1 and COX-2. In contrast to COX-1, 
which is a constitutively expressed enzyme involved in maintaining 
low levels of PG, COX-2 is induced in response to cell activations 
such as growth factors, cytokines, and phorbol esters, suggesting that 
this enzyme is involved in the generation of PG in inflammation. The 
induction of COX-2 in monocytes and the resulting production of 
PGE2 have been shown to be involved in the signal transduction 
pathway leading to the production of MMPs by these cells (Mertz et 
al., 1994). 
 In view of the interactions of COX-2 and MMPs, this study 
hypothesized that the inflammation via COX-2 and the production of 
MMPs might be involved in the development of atherosclerosis in 
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human aorta and coronary arteries. The aim of this study was to 
determine the cellular location of COX-2, and to investigate for 
codistribution of COX-2 and MMP-9. This study performed 
immunohistochemical staining on the atherosclerotic tissue sections 
obtained from paraffin embedded blocks that were positive to 
cytomegalovirus by in situ hybridization and polymerase chain 
reaction, by using antibodies to CMV late antigen, COX-2, MMP-9, 
macrophage and T-lymphocyte. 
 The purpose of this study was to determine the possible 
pathogenetic role of COX-2 and MMP-9 in cytomegalovirus-infected 
atherosclerotic aorta and coronary artery by histopathologic 
observation. 
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II. MATERIALS AND METHODS 
 
Materials  
The study population consisted of 23 persons (15 men and 8 
women; range of age, 21-65 years; mean age, 43 years) with 
atherosclerotic aorta and coronary artery, who were all referred to 
National Institute of Scientific Investigation (NISI; Seoul, Korea) for 
autopsy between April and October 2001. For control studies, aorta 
and coronary artery specimens, from which atherosclerotic lesions 
including fatty streak and plaque were excluded, were obtained from 
10 persons (6 men and 4 women; range of ages, 18-54 years; mean 
age, 36 years) who were died from traffic accidents. 
 
Tissue preparation 
Immediately following removal of aortic and coronary artery 
segments, each segment was fixed with 10% formalin in order to 
maintain vascular morphological integrity. To preserve the integrity of 
the adventitia and perivascular tissues, aorta and coronary artery 
specimens were carefully removed in a segment along with adjacent 
tissues and rinsed with PBS (phosphate buffered saline). Each 
segment was embedded in paraffin and cut in 5 µm sections, which 
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were stained with hematoxylin-eosin (H&E). Sections of these tissues 
were also used for immunohistochemical staining. One lesion from 
each section, which had morphological characteristics of 
atherosclerosis ranging from fatty streak to complicated 
atherosclerosis lesion, was assigned for histopathologic analysis. 
 
Immunohistochemical stain for CMV late antigen, COX-
2, MMP-9, Macrophage, T-lymphocyte 
Mouse anti-cytomegalovirus (CMV) late antigen monoclonal 
antibody (Chemicon International, Temecula, CA, USA), mouse anti-
human cyclooxygenase-2 (COX-2) monoclonal antibody (BD 
Biosciences, San Jose, CA, USA), and rabbit anti-human matrix 
metalloproteinase-9 (MMP-9) polyclonal antibody (Chemicon 
International, Temecula, CA, USA) were used as the primary 
antibodies for immunohistochemical staining. To characterize the type 
of inflammatory cells, rabbit anti-human macrophage (CD68) 
monoclonal antibody (Lipshaw Immunon, Pittsburgh, PA, USA) and 
rabbit anti-human T-lymphocyte (CD45RO) monoclonal antibody 
(Lipshaw Immunon, Pittsburgh, PA, USA) were used for the 
immunohistochemical staining. Peroxidase-conjugated secondary 
antibodies were used with these primary antibodies. 
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The paraffin sections (5 µm) were made and transferred to poly-L-
lysine coated glass slides (PolysineTM, Portsmouth, NH, USA). The 
paraffin sections were deparaffinized and rehydrated through the 
following solution: xylene, 3 times for 3 minutes in each, and serially 
100%, 95%, 80%, 75%, and 70% ethyl alcohol for 3 minutes in each. 
The sections were then treated with 3% H2O2 for 10 minutes to 
suppress endogenous peroxidase activity. The sections were boiled in 
plastic container which was filled with 10 mM sodium citrate, pH 6.0 
for 5 minutes with microwave oven (800W) to retrieve antigen sites, 
and cooled at room temperature for 20 minutes, followed by washing 
in TBS (Tris buffered saline; pH 7.2) for 5 minutes. Nonspecific 
binding was blocked by incubation with 10% normal goat serum for 
polyclonal antibodies and 10% normal horse serum for monoclonal 
antibodies. The sections were incubated at room temperature in moist 
chamber for 1 hour with primary antibodies (1:40 diluted anti-CMV 
late antigen, 1:50 diluted anti-MMP-9, 1:100 diluted anti-COX-2, 
1:200 diluted anti-macrophage, 1:200 diluted anti-T-lymphocyte). 
After washing and bathing in TBS (Tris buffered saline; pH 7.2) for 5 
minutes, the biotinylated secondary antisera cocktail including goat 
anti-mouse and anti-rabbit IgG diluted 1:400 was incubated on the 
slides for 20 minutes at room temperature in a moist chamber. The 
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sections were then processed by the streptoavidin-biotin-peroxidase 
complex method using the LSAB plus kit (DAKO Inc, Carpinteria, 
CA, USA), and stable AEC substrate solution (3-amino-9-
ethylcarbazole) was used as a chromogen. Gill’s hematoxylin was 
used as a counterstain, and sections were dehydrated, cleared, and 
mounted. 
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III. RESULTS 
 
Histopathologic Analysis 
 The sections of aorta and coronary artery taken from control 
groups showed no histological evidence of atherosclerosis, except 
minimal intimal thickening, and normal patterns of elastic media 
(Figure II-1, panel A; Figure II-2, panel A). In contrast to the control 
group, lesions that ranged from fatty streak to complicated 
atherosclerotic plaque were noted in all persons with atherosclerosis, 
and showed a thickened intima and fragmented elastic lamina. There 
was also prominent inflammatory infiltration with mononuclear cells 
and foam cells in atherosclerotic plaque, especially in the central core, 
and to a lesser extent in the inner media and adventitia. 
 
Immunohistochemical Stain 
Serial sections of each tissue samples (aorta and coronary artery) 
were examined sequentially for viral antigen, and for correlation of 
virologic results with histopathologic findings. Positive staining 
reactions observed in the aorta and coronary artery tissue sections with 
immunohistochemical stain are illustrated in Figures II-1 through II-3. 
CMV was demonstrated in occasional cells in the luminal surface and 
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in focal clusters of spindle-shaped or ‘foamy’ cells in the 
subendothelium as well as deeper intimal layers. Although the 
histogenesis of these cells has not been definitely established, they 
corresponded to endothelial cells, smooth muscle cells, or 
monocytes/macrophages on the basis of morphology and tissue 
location. 
Sections from control specimens showed little immunoreactivity 
for CMV late antigen, COX-2, MMP-9, macrophage, and T-
lymphocyte in the minimal thickened intima, and no 
immunoreactivity in the media (Figure II-1, panel B & C; Figure II-2, 
panel B & C). In atherosclerotic sections (plaque with central core), 
however, CMV late antigen was stained within the plaque 
macrophages/mononuclear cells (Figure II-3, panel A & D). The 
immunoreactivity for COX-2 and MMP-9 was evident in all cases of 
atherosclerosis along with plaques, mainly in macrophages/foamy 
cells, intimal and medial smooth muscle cells, and endothelial cells of 
the intima (Figure II-1, panel E & F; Figure II-2, panel E & F). Within 
the intima, the increased immunoreactivity for COX-2, MMP-9 was 
colocalized to the area stained with CMV late antigen. 
Immunoreactive patterns of COX-2 and MMP-9 were similar. 
Immunoreactivity for macrophage and T-lymphocyte were found in a 
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similar pattern and distribution with COX-2, MMP-9 (Figure III-3, 
panel B, C, E, and F). In fatty streak, immunoreactive patterns for 
COX-2, MMP-9, macrophage, and T-lymphocyte were similar, 
although immunoreactivity was less prominent. 
The immunoreactivity for COX-2 and MMP-9 increased in the 
atherosclerotic plaques itself, predominantly in the surrounding area 
of immunoreactive cytomegalovirus. These finding support that 
cytomegalovirus may participate in a pathogenetic mechanism for 
atherogenesis or progression of atherosclerosis. 
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Figure II-1. Hematoxylin-eosin stain, immunohistochemical stain 
for COX-2 and MMP-9 of control (panel A-C, respectively, ×100) 
and atherosclerotic aortas (panel D-F, respectively, ×40; small box 
in panel, ×400). Normal aorta (panel A) showed normal pattern of 
elastic media. Compared with controls, there was prominent 
inflammatory infiltration with mononuclear cells and foam cells in the 
atherosclerotic plaque (panel D). In nonatherosclerotic section (panel 
B & C), immunoreactivity for COX-2 and MMP-9 were not shown. 
Atherosclerotic lesion (panel E & F) demonstrated strong 
immunoreactivity for COX-2 and MMP-9.
COX-2H & E MMP-9
D E F
H & E COX-2 MMP-9
A B C
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Figure II-2. Hematoxylin-eosin stain, immunohistochemical stain 
for COX-2 and MMP-9 of control (panel A-C, respectively, ×100) 
and atherosclerotic coronary artery (panel D-F, respectively, ×40; 
small box in panel, ×400). Normal coronary artery (panel A) showed 
normal pattern of elastic media. Compared with controls, there was 
prominent inflammatory infiltration with mononuclear cells and foam 
cells in the atherosclerotic plaque (panel D). In nonatherosclerotic 
section (panel B & C), immunoreactivity for COX-2 and MMP-9 were 
not shown. Atherosclerotic lesion (panel E & F) demonstrated strong 
immunoreactivity for COX-2 and MMP-9. 
H & E COX-2 MMP-9
D E F
H & E COX-2 MMP-9
A B C
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Figure II-3. Immunohistochemical stain for CMV late antigen, 
macrophage, T-lymphocyte of atherosclerotic aorta (panel A-C, 
respectively, ×40; small box in panel ×400) and coronary artery 
(panel D-F, respectively, ×40; small box in panel ×400). The 
immunoreactivity to CMV was primarily located in endothelial lining 
of the vascular wall (panel A & D). The immunoreactivity for 
macrophages (panel B & E) and for T-lymphocytes (panel C & F) was 
shown. Note the similar distribution of macrophages and T-
lymphocytes in the coronary artery (panel E & F).
CMV Macrophage T lymphocyte
D E F
CMV Macrophage T lymphocyte
A B C
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IV. DISCUSSION 
 
 Atherosclerosis and its related diseases, in particular myocardial 
infarction (MI) and coronary heart disease (CHD), are a major cause 
of the morbidity and mortality worldwide. The differences in the 
prevalence of conventional atherosclerotic risk factors (such as 
smoking, hypertension, diabetes mellitus, and hypercholesterolemia) 
do not fully account for the variation in the prevalence or severity of 
atherosclerosis. Consequently, there is intense research interest 
focused on seeking other atherogenic risk factors. 
 Current data supports the hypothesis that atherosclerosis is an 
inflammatory disease rather than a degenerative disease owing to 
hemodynamic loading (Ross et al., 1993; Alexander et al., 1994) and 
studies examining markers of inflammation (e.g., C-reactive protein) 
demonstrate a relationship between an increasing inflammation and 
the risk of a vascular event. It is also recognized that plaque activity 
and the function of the cellular components can be a more important 
determinant of the clinical manifestations of atheroslcerosis than the 
degree of stenosis of the arterial lesions. Although many factors may 
initiate atherosclerosis, the process ultimately involves an 
inflammatory state in which macrophages and T-lymphocytes play a 
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major role (Jonasson et al., 1986; Ridker et al., 1997; Liuzzo et al., 
1994; van der Wah et al., 1994). 
 Inflammation appears to have a major role in the development of 
atherosclerosis. Cyclooxygenase-2 (COX-2) is involved in the 
inflammatory response via the generation of prostanoids that, in turn, 
are involved in the production of matrix metalloproteinase-9 (MMP-9). 
This study aimed to investigate atherosclerosis in human aorta and 
coronary arteries for in situ tissue distribution of COX-2, MMP-9, 
macrophage, and T-lymphocyte. Immunohistochemical studies were 
performed on atherosclerotic lesions of aorta and coronary arteries 
from persons who were all referred to National Institute of Scientific 
Investigation (NISI; Seoul, Korea) for autopsy, by using antibodies to 
CMV late antigen, COX-2, MMP-9, macrophage, and T-lymphocyte. 
All specimens from diseased aorta and coronary arteries had 
atherosclerotic lesions ranging from fatty streak to atherosclerotic 
plaques. In control, there was no expression of COX-2, MMP-9, 
macrophage, and T-lymphocyte. Immunoreactivity for COX-2 was 
predominantly noted in macrophages and smooth muscle cells (SMCs) 
of the intima including atherosclerotic plaque itself and the medial 
layer of the plaque base. Immunoreactivity for MMP-9 was found in 
the same distribution as that of COX-2. This study demonstrates that 
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COX-2 is coexpressed with MMP-9 by macrophages and SMCs in 
atherosclerotic lesions. Thus, vascular inflammatory reactions may 
influence extracellular matrix remodeling by coactivation of MMP-9 
in the development of atherosclerosis and, in turn, the progression of 
disease. 
 There is a growing amount of evidence to support an association 
between infection and atherosclerosis, with the first suggestion of a 
link being made by Osler early in this century. Since Fabricant et al. 
(1978) first reported that herpesviruses infection is as a risk factor for 
atherosclerosis, a number of seroepidemiological studies have shown 
a positive relationship between cytomegalovirus infection and 
atherosclerosis (Peterson et al., 1980; Benditt et al., 1983; Grattan et 
al., 1989). The results of in situ hybridization and PCR study also 
demonstrated a positive association between cytomegalovirus 
infection and atherosclerosis, so the present study suggest that 
cytomegalovirus may play a pathogenetic role in atherosclerosis.  
 As mentioned above, vascular inflammation and a chronic 
degenerative process are prerequisite for atherosclerosis. NF-kB, a 
ubiquitous transcription factor of particular importance in immune and 
inflammatory responses, increases the expression of the genes for 
many cytokines, enzymes, and adhesion molecules in chronic 
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inflammatory diseases. This increased expression is reflected by an 
increased amount of nitric oxide, which has a cytotoxic effect on 
vascular tissue. Cyclooxygenase-2 (COX-2) another inducible enzyme 
regulated by NF-kB, is responsible for the increased production of 
prostaglandins (PG) and thromboxane (TXA) in inflammatory 
diseases (Mertz et al., 1994). Two types of COX isoform have been 
identified, referred to as COX-1 and COX-2. In contrast of COX-1, 
which is a constitutively expressed enzyme involved in maintaining 
low levels of PG, COX-2 is induced in response to cell activations 
such as growth factors, cytokines, and phorbol esters, suggesting that 
this enzyme is involved in the generation of PG in inflammation. The 
induction of COX-2 in monocytes and the resulting production of 
PGE2 have been shown to be involved in the signal transduction 
pathway leading to MMPs production in those cells (Wahl et al., 1977; 
Won et al., 1998). Induced COX-2 expression in monocytes-
macrophages and fibroblasts results in increased synthesis of PGE2 
and TXA2, which mediate inflammatory change, vasoconstriction, and 
platelet aggregation. The increased synthesis of COX-2 is considered 
to play an important role in inflammation and tissue injury. COX-2, 
which is induced in many cell types in response to cytokines, 
metabolizes membrane phospholipid arachidonic acid and plays a role 
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in the expression of an inflammatory mediator in heart failure (Won et 
al., 1998). Gelatinase-B also known as 92-kDa gelatinase or MMP-9, 
may contribute importantly to the instability of human atherosclerotic 
plaques. The regulation of transcription of MMP-9 depends in part on 
a NF-kB element in its promoter sequence. This transcription factor is 
known to be regulated by oxidative stress and may link the 
accumulation of oxidized lipoproteins in the intima to expression of 
this particular protease (Aikawa et al., 1998). This study was designed 
to test the hypothesis that the immunoreactivity for CMV late antigen 
and inflammatory mediators such as COX-2 and MMP-9 will be 
colocalized to inflammatory cells in atheromatous plaque if 
cytomegalovirus has some pathogenetic role on atherosclerotic 
diseases. That is, if the vascular infection of cytomegalovirus could 
induce a chronic inflammatory reaction in host vascular tissue and 
activate inflammatory cells, some inflammatory mediators such as 
COX-2 and MMP-9 may exhibit increased expression surrounding 
macrophages, which have key role in atherosclerosis, infected with 
cytomegalovirus. The results of this study demonstrated that COX-2 
and MMP-9 were colocalized to the inflammatory infiltrates of 
diseased tissues, particularly within cytomegalovirus-stained 
macrophages/monocytes. 
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 Elevated lipids may play a role in initiating atherosclerotic lesion 
development by stimulating inflammatory cytokine production, which 
may in turn initiate the inflammatory process. Inflammatory cytokines 
were localized to macrophages and endothelial cells overlying 
atherosclerotic lesions. Minimally oxidized LDL and beta-VLDL 
upregulate inflammatory cytokines, thereby attracting more 
leukocytes to develop atherosclerotic plaque, beginning the cycle of 
inflammation and intimal development (Berliner et al., 1990; Wilcox 
et al., 1995). As well, oxidized LDL and vascular endothelial growth 
factor (VEGF) accumulated in human atherosclerotic lesions induces 
the production of macrophage VEGF (Ramos et al., 1998). Also, 
VEGF upregulates the expression of matrix metalloproteinases in 
vascular smooth muscle cells (Wang et al., 1998). Similar events may 
occur in the adventitia during atherosclerotic development where the 
adventitial vasa vasorum endothelial cells may be affected by elevated 
lipids and express adhesion molecule early in the atherosclerotic 
process, thus contributing to the invasion of inflammatory cells into 
the adventitia as well (Berliner et al., 1990; Wilcox et al., 1995; Wood 
et al., 1993) Experimental hypercholesterolemia may induce the 
upregulation of specific cell-surface receptors in the adventitial vasa 
vasorum, which then predisposes them to proliferate in response to 
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growth factors and an increase in the vessel wall thickness (Edelman 
et al., 1992; Isner et al., 1996; Kwon et al., 1998). Jamieson and co-
authors (1995) have demonstrated a correlation between apo(a) 
deposition within endothelial cells of vasa vasorum and the stage of 
atherosclerotic plaque, suggesting a specific link between apo(a) 
receptor and the pathogenesis of atherosclerosis. Several experimental 
studies have shown that in response to and increased presence of 
mildly oxidized lipoproteins in the outer media (Juul et al., 1996), 
which have been shown to be chemotactic for monocytes (Quinn et al., 
1987), an increased number of monocytes can enter the intima and 
adventitia under hypercholesterolemic conditions (Lewis et al., 1985). 
 This study documents that there was significant expression of 
COX-2 and MMP-9 in atherosclerosis aorta and coronary artery, but 
very little in control tissues. Immunoreactivity for COX-2 and MMP-9 
were colocalized to the inflammatory infiltrates, principally 
macrophages/foam cells in atherosclerotic intima, plaque itself, and 
vascular smooth muscle cells. In addition, these expressions were 
evident in the medial smooth muscle cells. These results suggest that 
COX-2 and MMP-9 have pathobiological roles in cytomegalovirus-
infected atheroslcerosis as the inflammatory mediator or its product, 
which may regulate cellular activation and reorganize extracellular 
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matrix. 
 Macrophages are known to play an important role in regulating 
the turnover of extracellular matrix (ECM) in both normal and 
pathologic conditions through the secretion of proteases, including 
MMPs, protease inhibitors, and cytokines. MMP expression in 
macrophages is dependent on prostaglandin E2 (PGE2) (Corcoran et 
al., 1992). PGE2 synthesized from arachidonic acid, and 
cyclooxygenase (COX) is the rate-limiting enzyme in this pathway. 
The activation of macrophages has been previously correlated with the 
induction of COX-2 (Arias-Negrete et al., 1995). Macrophages 
expressing COX-2 are known to produce eicosanoids that have 
proinflammatory effects, increasing vascular permeability, promoting 
chemotaxis, and favoring cell proliferation and cholesterol ester 
retention (Hajjar et al., 1992; Herschman et al., 1996). 
  Recent evidence is of particular relevance to the role of COX-2 in 
inflammation and atherosclerosis. COX-2 in activated human 
monocytes may be able to generate the prostaglandin, 8-epi-PGF2α, 
which is mitogenic leading to cellular proliferation, and 
vasoconstrictive leading to vasoconstriction, and thus may play a role 
in the genesis of atherosclerosis (Pratico et al., 1996; Fukunaga et al., 
1993; Takabashi et al., 1992). In this study, the immunolocalization 
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study confirmed the increased expression of COX-2 in atherosclerotic 
plaque, especially in macrophages. 
 Increased levels of several MMPs, including stromelysin, 
interstitial collagenase, and gelatinase A and B, show increased 
expression and/or activation in atherosclerotic plaques (Galis et al., 
1994; Henney et al., 1991; Galis et al., 1995; Lee et al., 1996; 
Zaltsman et al., 1997). Furthermore, MMP-9 expression and MMP-2 
expression and activation are positively correlated with lesion severity, 
consistent with a pathogenetic role in the late disease process 
(Zaltsman et al., 1997). The activation of MMPs and their proteolytic 
potential is tightly controlled by endogenous tissue inhibitors of 
matrix metalloproteinases (TIMPs) (Birkedal-Hansen et al., 1993; 
Cawston et al., 1996). This study showed coexpression of MMP-9 and 
COX-2 in macrophages and smooth muscle cells in intima and media, 
suggesting that inflammatory activation of MMP-9 as well as COX-2, 
may contribute to the enhanced local matrix degradation in 
atherosclerotic plaques. 
 The present study demonstrated that immunoreactivity for MMP-
9 and COX-2 were noted in the intimal smooth muscle cells. Vascular 
adhesion molecules like intercellular adhesion molecule-1 (ICAM-1) 
have been characterized in the endothelial cells of the vasa vasorum 
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(Szekanecz et al., 1994). These molecules aid in the recruitment of 
inflammatory cells to the aorta and stabilize local T-cell receptor 
function (Holmes et al., 1995). This finding suggested that 
inflammatory reaction was evident coupling with intimal hyperplasia. 
Linton et al. (1999) demonstrated that COX-2 expression was also 
found in aortic lesions of apoE-deficient mice in fatty streaks and 
complex atherosclerotic lesion areas using paraffin sections. These 
results were concordant with this study. 
 In conclusion, former part of this study (chapter I) evaluated the 
association between cytomegalovirus and atherosclerosis indirectly by 
in situ hybridization and PCR study and suggested here a possible 
pathogenetic mechanism of cytomegalovirus infection on 
atherosclerosis by histopathologic method. Later part of this study 
(chapter II) demonstrated the presence of both COX-2 and MMP-9 in 
atherosclerotic lesions of aorta and coronary artery. These findings 
support the hypothesis that COX-2 and MMP-9 may interact and play 
a role in this disorder.   
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CONCLUSIONS 
 
The purpose of this study was to examine the aorta and coronary 
artery of subjects with atherosclerosis for the presence of 
cytomegalovirus (CMV), and to evaluate the relationship between 
CMV infection and atherosclerosis.  
 
1. Verhoeff’s elastic tissue stain of atherosclerotic sections revealed 
that the elastic lamina was fragmented and disorganized. The 
structural changes of elastic lamina may play an important role in 
the development of matrix reorganization, resulting in vascular 
geometric remodeling. 
 
2. Of 23 subjects with atherosclerosis, CMV was detected by in situ 
hybridization in 60.9% (14/23) of aorta and 42.9% (9/21) of 
coronary arteries. In contrast, only one coronary artery of 10 
control subjects revealed hybridization for CMV.  
 
3. By in situ hybridization, CMV was localized in cells 
morphologically consistent with endothelial cells, smooth muscle 
cells, lymphocytes, fibroblasts and Schwann cells. 
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4. By PCR, CMV was detected in 65.2% (15/23) of aorta and 
52.4%(11/21) of coronary arteries in 23 subjects with 
atherosclerosis, and in 3 of aorta and coronary arteries in 10 control 
subjects. 
 
5. COX-2 and MMP-9 were colocalized to inflammatory infiltrates in 
atherosclerotic intima, plaque itself, and vascular smooth muscle 
cells, and coexpressed by macrophages and smooth muscle cells. 
 
6. Inflammatory activation of MMP-9 as well as COX-2 may 
contribute to the enhanced local matrix degradation in 
atherosclerotic plaques. 
 
7. The presence of COX-2 and MMP-9 were demonstrated in 
atherosclerotic lesions of aorta and coronary artery, and these 
findings support the hypothesis that COX-2 and MMP-9 may 
interact and play a role in atherosclerosis. 
 
In conclusion, these results suggest that cytomegalovirus is 
present in the early or advanced atherosclerotic lesions of human 
aorta and coronary artery. CMV associated vascular inflammatory 
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reactions and extracellular matrix remodeling may influence in the 
development of atherosclerosis and, in turn, progression of disease. 
CMV may potentially play a direct or indirect role in the 
pathogenesis of human atheroslcerosis. 
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국문 요약 
 
 
Cytomegalovirus가 감염된 동맥경화성 대동맥
과 관상동맥에서 Cyclooxygenase-2와 Matrix 
Metalloproteinase-9의 역할 
 
 
동맥경화증의 병인론 중 고지혈증, 고혈압, 당뇨, 비만, 흡
연, 고령, 남성, 가족력, 유전자변이 등은 위험인자로 이미 잘 
알려져 있다. 그러나, 최근 감염체와 만성 염증이 동맥경화증
의 중요한 원인으로 제시되고 있고, 이 중 특히, 
cytomegalovirus (CMV), herpes simplex virus type 1 (HSV-1), 
Epstein-Barr virus (EBV), Chlamydia pneumoniae, 그리고 
Helicobacter pylori 등이 유력한 원인체로 보고되고 있다. 
본 연구는 CMV에 의한 혈관내 감염이 만성 염증성 반응을 
유도하고, 활성화된 염증세포들이 염증 매개물질인 
cyclooxygenase-2 (COX-2)와 matrix metalloproteinase-9 (MMP-9)
등을 발현하여 동맥경화증을 유발하는지를 알아 보고자 하였
다. 먼저 in situ hybridization 과 polymerase chain reaction 방법으
로 동맥경화증 병변에서 CMV를 검출하여 상호 연관성을 평
가하였고, 다음 CMV가 감염된 동맥경화증 병변에서 염증 매
개물질인 COX-2와 MMP-9의 발현을 면역조직화학염색 방법
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으로 확인하였다.  
우선 동맥경화증 병변이 있는 23건과 대조군 10건에서 
CMV 감염 정도를 평가한 결과 in situ hybridization 방법으로는 
동맥경화성 대동맥 23건 중 14건 (60.9%), 관상동맥경화증 21
건 중 9건 (42.9%)에서 CMV가 검출되었고, polymerase chain 
reaction 방법으로는 동맥경화성 대동맥 23건 중 15건 (65.2%), 
관상동맥경화증 21건 중 11건 (52.4%)에서 CMV가 검출되었
다. 대조군인 대동맥과 관상동맥 각 10건 (총 20건) 중에서는 
3건만이 검출되었다.  
이상과 같이 CMV의 존재가 확인된 동맥경화증 병변을 선
정하여 CMV late antigen, COX-2, MMP-9, macrophage, T-
lymphocyte에 대한 항체로 면역조직화학염색을 시행한 결과, 
CMV가 검출되었던 부위가 COX-2와 MMP-9에 대해 양성 반
응을 보였다. 이러한 결과로 CMV는 동맥경화증 생성과정에 
염증 반응을 일으키면서 병인론적으로 관여하여 동맥경화증
을 악화시키는 것을 확인 하였다.  
CMV probe는 smooth muscle cells, endothelial cells, lymphocytes, 
fibroblasts, Schwann cells 등의 세포들에서 hybridization 되었으
나 특징적인 바이러스 봉입체를 포함한 세포에서는 
hybridization이 관찰되지 않았는데, 이것은 동맥벽의 CMV 감
염이 잠복감염 임을 시사한다. 
결론적으로 이상의 실험 결과 CMV가 동맥경화증의 병인론
에 직⋅간접적으로 관여함을 알 수 있었으며, 이러한 감염체의 
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항바이러스제제에 의한 치료가 동맥경화증 예방에 기여할 것
으로 생각된다.  
 
 
 
 
 
 
 
 
 
 
 
 
__________________________________________________________ 
핵심어: cytomegalovirus (CMV), atherosclerosis, cyclooxygenase-2 
(COX-2), matrix metalloproteinase-9 (MMP-9), in situ hybridization 
(ISH), polymerase chain reaction (PCR), immunohistochemical stain 
 
